These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 28352025

  • 21. Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report.
    Nagarajah S, Tepel M, Nielsen C, Assing K, Palarasah Y, Andersen LLT, Lange LB, Bistrup C.
    BMC Nephrol; 2019 Aug 07; 20(1):307. PubMed ID: 31390992
    [Abstract] [Full Text] [Related]

  • 22. Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.
    Volokhina EB, van de Kar NC, Bergseth G, van der Velden TJ, Westra D, Wetzels JF, van den Heuvel LP, Mollnes TE.
    Clin Immunol; 2015 Oct 07; 160(2):237-43. PubMed ID: 26111482
    [Abstract] [Full Text] [Related]

  • 23. ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB.
    Chaudoir C, Ong MG, Gu X, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Oct 07; 168(1):12-5. PubMed ID: 26986861
    [Abstract] [Full Text] [Related]

  • 24. [Eculizumab treatment of atypical hemolytic uremic syndrome].
    Sawai T, Okudo Y, Sakai T.
    Nihon Jinzo Gakkai Shi; 2014 Oct 07; 56(7):1090-6. PubMed ID: 25420410
    [No Abstract] [Full Text] [Related]

  • 25. Late renal recovery after treatment over 1 year post-onset in an atypical hemolytic uremic syndrome: a case report.
    Kuroki Y, Mitsuiki K, Nakagawa K, Tsuruya K, Katafuchi R, Hirakata H, Nakano T.
    BMC Nephrol; 2020 Jun 22; 21(1):236. PubMed ID: 32571244
    [Abstract] [Full Text] [Related]

  • 26. Atypical Hemolytic Uremic Syndrome After Kidney Transplantation: Lessons Learned From the Good, the Bad, and the Ugly. A Case Series With Literature Review.
    Fayek SA, Allam SR, Martinez E, Pan G, Dao A, Rofaiel G.
    Transplant Proc; 2020 Jun 22; 52(1):146-152. PubMed ID: 31924403
    [Abstract] [Full Text] [Related]

  • 27. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M, Tanabe K.
    Nephrology (Carlton); 2016 Jul 22; 21 Suppl 1():9-13. PubMed ID: 26988663
    [Abstract] [Full Text] [Related]

  • 28. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 22; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recent advances in the management of atypical hemolytic uremic syndrome.
    Cataland SR.
    Clin Adv Hematol Oncol; 2012 Aug 22; 10(8):537-9. PubMed ID: 23073053
    [No Abstract] [Full Text] [Related]

  • 31. Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.
    Yamada Y, Abe R, Okano Y, Miyakawa Y.
    Intern Med; 2017 Aug 22; 56(9):1085-1088. PubMed ID: 28458317
    [Abstract] [Full Text] [Related]

  • 32. Hypertensive choroidopathy in atypical hemolytic-uremic syndrome.
    Polito MS, Machetta F, Fea AM, Eandi CM.
    Eur J Ophthalmol; 2021 Mar 22; 31(2):NP63-NP66. PubMed ID: 31875682
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.
    Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.
    J Am Soc Nephrol; 2019 Dec 22; 30(12):2449-2463. PubMed ID: 31575699
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.